» Articles » PMID: 18812462

Evaluating the Glucose Tolerance Test in Mice

Overview
Date 2008 Sep 25
PMID 18812462
Citations 363
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study was to determine the optimal conditions under which to assess glucose tolerance in chow- and high-fat-fed C57BL/6J mice. Mice were fed either chow or high-fat diet for 8 wk. Variables tested were fasting duration (0-, 3-, 6-, and 24-h and overnight fasting), route of administration (intraperitoneal vs. oral) load of glucose given (2, 1, or 0.5 g/kg and fixed 50-mg dose), and state of consciousness. Basal glucose concentrations were increased in high-fat- compared with chow-fed mice following 6 h of fasting (9.1 +/- 0.3 vs. 7.9 +/- 0.4 mmol/l P = 0.01). Glucose tolerance was most different and therefore significant (P = 0.001) in high-fat-fed mice after 6 h of fasting (1,973 +/- 96 vs. 1,248 +/- 83 mmol.l(-1).120 min(-1)). The difference in glucose tolerance was greater following an OGTT (142%), in contrast to an IPGTT, with a 127% difference between high fat and chow. We also found that administering 2 g/kg of glucose resulted in a greater level of significance (P = 0.0008) in glucose intolerance in high-fat- compared with chow-fed mice. A fixed dose of 50 mg glucose regardless of body weight was enough to show glucose intolerance in high-fat- vs. chow-fed mice. Finally, high-fat-fed mice showed glucose intolerance compared with their chow-fed counterparts whether they were tested under conscious or anesthetized conditions. We conclude that 2 g/kg glucose administered orally following 6 h of fasting is best to assess glucose tolerance in mice under these conditions.

Citing Articles

Islet hormones at the intersection of glucose and amino acid metabolism.

White P, Wewer Albrechtsen N, Campbell J Nat Rev Endocrinol. 2025; .

PMID: 40055529 DOI: 10.1038/s41574-025-01100-4.


Effects of celastrol on the heart and liver galaninergic system expression in a mouse model of Western-type diet-induced obesity and metabolic dysfunction-associated steatotic liver disease and steatohepatitis.

Canova N, Sipkova J, Arora M, Pavlikova Z, Kucera T, Seda O Front Pharmacol. 2025; 16:1476994.

PMID: 39968178 PMC: 11832397. DOI: 10.3389/fphar.2025.1476994.


The potential of fruit ethanolic extract as a solution for hyperglycemia, uremia, and hypercreatininemia in mice ().

Ruyani A, Suswati E, Pratiwi D, Elvia R, Oktoviani O, Parlindungan D Open Vet J. 2025; 14(12):3296-3308.

PMID: 39927360 PMC: 11799630. DOI: 10.5455/OVJ.2024.v14.i12.14.


Effects of Cirsium japonicum var. maackii on avelliation of metabolic disease by improving insulin resistance.

Yoon H, Jang Y, Paik H, Choi H, Choi J, Kwon J Lab Anim Res. 2025; 41(1):3.

PMID: 39815341 PMC: 11737197. DOI: 10.1186/s42826-025-00234-w.


Systemic Glucose Homeostasis Requires Pancreatic but Not Neuronal ATP-sensitive Potassium Channels.

Li A, Tsai W, Tsai W, Yang S Function (Oxf). 2025; 6(1).

PMID: 39809576 PMC: 11815579. DOI: 10.1093/function/zqaf002.